We take a bespoke approach to all our trials. We understand every therapeutic area is different. We performed a careful review of trial design, inclusion/exclusion criteria, and review of the specific needs and/or study participation challenges expressed by diverse patients and providers to do our part to reduce barriers and support clinical trial equity.
Offering a flexible approach, Science 37 were able to quickly enroll a more representative patient population for real-world diagnostic study in the field of oncology.
Download the full case study for more insight.
Please contact us at sales@science37.com to learn more about how we enable diversity in clinical trials.